✨ Welcome to the Season of Hope ✨ As we enter the final months of the year, the Season of Hope invites us to pause—and reflect on why we do what we do. At Terumo Blood and Cell Technologies, our work is rooted in one purpose: to unlock the potential of blood and cells to improve lives. Whether through innovation, partnership, or patient care, every solution we bring forward exists to give someone more time, more healing, and more hope. This season gives us the opportunity to reconnect with that purpose. Throughout November and December, we’ll be sharing stories, innovations, and moments that highlight how hope comes to life in our work—from collection to therapy, from insight to impact. 💝 Join us as we reflect, reconnect, and look ahead with intention. Because when we unlock the potential of blood and cells, we unlock the potential of hope. #SeasonofHope #UnlockingPotential #WhyWeDoWhatWeDo #HealthcareInnovation #PatientImpact #TerumoBCT #BloodAndCellTherapies
Terumo Blood and Cell Technologies
Medical Equipment Manufacturing
Lakewood, Colorado 104,460 followers
The official LinkedIn page of Terumo Blood and Cell Technologies. Contributing to Society Through Healthcare
About us
Headquartered in Lakewood, Colorado, Terumo Blood and Cell Technologies is a global leader in blood component, therapeutic apheresis and cellular technologies serving customers in more than 150 countries. As the only company with the unique combination of apheresis collections, manual and automated whole blood processing and pathogen reduction, we believe in the potential of blood to do even more for patients than it does today. This belief unites our organization, inspires our innovation and strengthens our collaboration with customers. Originally established in 1964 as COBE Laboratories, today, nearly 7,900 associates around the world are deeply committed to our vision of working together for better lives and our promise to unlock the potential of blood and cells. One way we back these words is through our pledge to be a conscientious corporate citizen and conduct our business in a way that provides social, environmental and economic benefit. At Terumo Blood and Cell Technologies, discovery never stops. We share a passion for thinking in new and different ways and we are proud to support education and research through a variety of community involvement activities as well as by providing grants to advance treatment options for patients. We know the work we do matters and has the potential to fundamentally improve health care. We remain dedicated to ensuring the lifesaving gift of blood is available around the world and to meeting and exceeding the needs of our customers and the patients we ultimately serve. If you are the best at what you do, we invite you to explore career opportunities with us now! We have careers in: • R&D • IT • Engineering • Clinical Sciences • Manufacturing • Software Development • Quality and Regulatory Social Media Policy: https://www.terumo.com/socialmedia_policy
- Website
-
http://www.terumobct.com
External link for Terumo Blood and Cell Technologies
- Industry
- Medical Equipment Manufacturing
- Company size
- 5,001-10,000 employees
- Headquarters
- Lakewood, Colorado
- Type
- Public Company
- Founded
- 1964
- Specialties
- blood component separation and processing, therapeutic apheresis, cellular technologies, and regenerative medicine
Products
TOMEs
Core Banking Systems
TOMEs allows you to integrate, manage and monitor your TOMEs-compatible devices, working across your business and with your blood bank information system (BBIS).
Locations
-
Primary
Get directions
11158 W Collins Ave
Lakewood, Colorado 80215, US
Employees at Terumo Blood and Cell Technologies
-
Jonas Vezbergas
-
Mike Rivera
Helping organizations navigate the complexities they face to understand their customers and to produce meaningful products and services.
-
Claudia Formiga
Head of Global Corporate Communications
-
Rita Hermann
Digital Transformation Leader | Strategic Leadership | Innovation Management
Updates
-
🌟 Meet the visionaries driving patient access to advanced therapies! 🌟 On 11 December 2025, leading experts from across the advanced therapy ecosystem will gather at PwC Campus in Brussels to break down barriers and accelerate patient access to transformative treatments. Get inspired by our incredible keynote speakers, including: 🔹 Rainer Becker – Director for Health and Food Safety, European Commission 🔹 Prof. Dr. Christian CHABANNON – Head of Cell Therapy Facility, Institut Paoli-Calmettes 🔹Dr. Tim Desmet - Business Developer Advanced Cell and Tissue Therapies, UZ Gent/Ghent University 🔹Konstantinos Lykopoulos – Executive Director Global Value and Access, Kite Pharma 🔹Emily Merrell – Director of Advanced Therapy Treatment Centre Network, Cell and Gene Therapy Catapult 🔹Sarah Snykers – Head of Operations, Legend Biotech 🔹Samuel Speltdoorn – Global Head of Healthcare solutions, NX GROUP (NIPPON EXPRESS GROUP) 🔹Dr. Jeroen Van den Bossche, PhD – Director Equity Sales – Life Sciences, KBC Securities Moderated by our Terumo Blood and Cell Technologies and PwC Belgium team: 🔹Jan Debaere - Partner Health Industries Belgium, PwC Belgium 🔹Koenraad Dierick, MBA – Vice President of Patient Access, Terumo Blood and Cell Technologies 🔹Veerle d'Haenens – General Manager, Global Therapy Innovations, Terumo Blood and Cell Technologies 🔹Dr. Antje K. – Senior Manager, Global Market Development for Cell and Gene Therapies, Terumo Blood and Cell Technologies 🔹Dr. Natalia Violato, Ph.D – ATMP expert, PwC Belgium 🔹Dr. Kim Vriens – Value-based healthcare and innovation consultancy lead, PwC Belgium 🎤 Together, we’ll share unique insights on the scientific, regulatory, and commercial challenges of advanced therapy medicinal products (ATMPs), and explore collaborative solutions to unlock patient access globally. 🗓️ When: 11 December 2025 📍 Where: PwC Belgium, Culliganlaan 5, 1831 Diegem 🔗 Don’t miss your chance to learn, connect, and contribute: Register now 👉 https://pwc.to/4qd3nDX Join us and be part of a movement shaping the future of advanced therapies. Together, we can break the barriers that stand between patients and life-changing treatments. #ATMP #AdvancedTherapies #PatientAccess #CellTherapy #HealthcareInnovation #PwCBelgium #TerumoBCT
-
-
📲 “Sorry, Vivienne — lost you there for a moment! I’ve got the rest of the world to show you …” Sheila Doshi is back (with a better signal this time), picking up where the first video call left off — and this time, she’s taking Vivienne Wint - RGN INMP (and all of us) on a whirlwind tour through China, Australia, Japan, Brazil, India, and the U.S. From live training in Tamil to expert guidance in Mandarin, this call back reminds us that no matter the country, the language, or the specialty — our trainers are united by one mission: empowering others to unlock better care. 🌍 Different regions. Same commitment. Better Together. #BetterTogether #GlobalTraining #TBCTAroundTheWorld #HealthcareHeroes #TrainingMatters
-
📲 “Sheila, are you there? I can’t — wait, now I hear you!” Peek into Vivienne Wint - RGN INMP’s video call with Sheila Doshi as she spotlights how EMEA trainers are turning expertise into real-world impact through hands-on Spectra Optia Apheresis System trainings. From expert trainers in the U.K. and France to dedicated teams in Turkey, Egypt, and Italy, this lively video call captures the heart of what makes us Better Together: people showing up for one another, across borders and time zones, to improve patient care. #BetterTogether #TrainingMatters #GlobalConnection #TerumoBCTAroundTheWorld #HealthcareEducation
-
At #AABB2025, we were inspired by the powerful stories shared on our interactive wall from donors and advocates whose experiences remind us of the real impact of blood and cell donation. Our Terumo Blood and Cell Technologies leaders also weighed in on the event’s key moments, highlighting how innovation and partnership continue to drive progress in #PatientCare. If you couldn’t join us in person, catch our event highlights to hear directly from our associates about what made this gathering so meaningful. These moments, from the personal to professional, remind us that advancing healthcare isn’t something we do alone. It takes people, ideas, and purpose coming together across the globe. Because at the heart of every donation, every collaboration, and every life touched, we’re always Better Together. #BetterTogether #AABB2025 #UnlockingPotential #WhyIDonate #CollaborationInCare #TerumoBCT
-
The Science & Innovation Theater sessions at #AABB2025 have been incredible. We’ve been exploring innovations in cell collection and hearing early adopters share valuable insights from the successful implementation of the Reveos Automated Blood Processing System. Couldn’t join us in person? Stay tuned for our upcoming webinar featuring early adopters. Got questions? Drop them in the comments — we’d love to hear from you! #RevolutionaryReveos #BetterTogether #UnlockingPotential #WhyIDonate #CollaborationInCare #TerumoBCT
-
Compartimos días muy inspiradores en el LXVI Congreso Nacional de Hematología, organizado por la Agrupación Mexicana para el Estudio de la Hematología (AMEH). Agradecemos a todos los que visitaron nuestro stand, intercambiaron ideas con nuestros expertos y exploraron nuestro portafolio de innovadoras tecnologías relacionadas con la sangre y las células. Realmente nos inspira su colaboración y compromiso con el avance de la hematología y la mejora de los resultados en los pacientes. En Terumo Blood and Cell Technologies, creemos que el progreso más significativo ocurre cuando trabajamos juntos. Al aprovechar al máximo el potencial de la colaboración, abrimos nuevos caminos hacia la innovación. 💬 Construyamos juntos el próximo capítulo de la salud. 👉 Descubra cómo podemos colaborar en su próximo paso: https://bit.ly/3WULtbM #BetterTogether #UnlockingPotential #TerumoBCT #AMEH2025 #Hematology #BloodCollection #TherapeuticApheresis #CellandGeneTherapy #GlobalBloodSolutions
-
-
We’re excited to introduce our interactive community impact wall at #AABB2025! Stop by our booth to share your personal story and answer the question: Why do you donate? If you can’t make it to San Diego, don’t worry — we want to hear from you, too! Join the conversation by commenting below or sharing your story using #WhyIDonate. Let’s celebrate the power of blood donation together. See you at Booth 1321. #BetterTogether #UnlockingPotential #CollaborationInCare #TerumoBCT
-
Terumo Blood and Cell Technologies reposted this
The future of cell and gene therapy runs through the blood center community. 🩸✨ At AABB's Annual Meeting next week, the BCAR - The Blood and Cells Advocacy Roster Biotherapies Pavilion panel brings together innovators and operators to discuss how blood centers are: ♦️ Extending clinical capabilities to support CGT delivery ♦️ Partnering with hospitals and manufacturers ♦️ Overcoming barriers to access, quality, and reimbursement 📅 Monday, October 27 ⏰ 9:30am PT 📍 Biotherapies Pavillion 👤 Moderator: Kate Fry, MBA, CAE (America's Blood Centers) 👥 Panelists: Becky Cap (Vitalant), Scott Grady (Versiti Inc.), Trevor S. (Terumo Blood and Cell Technologies) & Heather Munoz, MN, RN, CPN, CPHON, QIA (BioBridge Global) #AABB2025 #CGT #Biotherapies #BloodCenters #InnovationInHealthcare #FutureOfMedicine #BCAR https://lnkd.in/eZWpqZ_7
Another session for your AABB schedule... After a year of highlighting the untapped infrastructure and expertise within the blood center community, BCAR - The Blood and Cells Advocacy Roster is showcasing how these capabilities are being put into action to support real-world delivery of advanced biotherapies. Join moderator, Kate Fry, MBA, CAE (America's Blood Centers), as well as Becky Cap (Vitalant), Scott Grady (Versiti Inc.), Trevor S. (Terumo Blood and Cell Technologies) and Heather Munoz, MN, RN, CPN, CPHON, QIA (BioBridge Global) for this session to hear real examples of blood centers partnering across the ecosystem to bring cell and gene therapies to patients — turning potential into practice. 🩸Building the bridge from proven infrastructure to next-generation therapies. #CellAndGeneTherapy #Biotherapies #BloodCenters #HealthcareInnovation #BCAR #AABB
This content isn’t available here
Access this content and more in the LinkedIn app
-
Terumo Blood and Cell Technologies reposted this
📊 Data saves lives... when it’s connected. At our roundtable at this year's AABB Annual Meeting, we’re unpacking how interoperable data can enhance transfusion outcomes and accelerate access to advanced therapies. Key topics include: ♦️ Building interoperable data systems across blood centers, hospitals & developers ♦️ Linking donor, product & patient data to improve therapy outcomes ♦️ Strengthening traceability and cybersecurity in the data flow 💬 Expect a fast-paced, solution-oriented discussion using real-world case studies in sickle cell disease, and walk away with actionable ideas for your organization. 📅 Sunday, October 26 ⏰ 12:30pm PT 📍 SDCC 26B 👥 Chetan Makam (Terumo Blood and Cell Technologies), Jeff Wren (AABB), Becky Cap (Vitalant) & Jonathan Wofford (Title21 Health Solutions) #AABB2025 #BCAR #DataInHealthcare #DigitalHealth #CellAndGeneTherapy #SickleCell https://lnkd.in/ezfvP9YF
Heading to AABB's Annual Meeting this week? Join us for our roundtable on 'Leveraging Data Sharing to Enhance Patient Access, Clinical Efficiency, and Therapy Delivery Capacity'. In just one hour, we’ll unpack real-world data challenges and opportunities across transfusion medicine and cell & gene therapies, using sickle cell disease as a case study. Expect a focused, interactive discussion led by Chetan Makam (Terumo Blood and Cell Technologies), Becky Cap (Vitalant), Jonathan Wofford (Title21 Health Solutions), Jeff Wren (AABB), and others — exploring how interoperability, integration, and innovation can unlock better outcomes for patients and providers alike. 🩸 Because when data flows, care improves. #AABB #DataSharing #TransfusionMedicine #CellAndGeneTherapy #Interoperability #HealthcareInnovation
This content isn’t available here
Access this content and more in the LinkedIn app